A NEW REGIMEN OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - EFFICACY WITHOUT SIGNIFICANT TOXICITY

被引：40

作者：

EBERLEIN, TJ ^{[1
]}

SCHOOF, DD ^{[1
]}

JUNG, SE ^{[1
]}

DAVIDSON, D ^{[1
]}

GRAMOLINI, B ^{[1
]}

MCGRATH, K ^{[1
]}

MASSARO, A ^{[1
]}

WILSON, RE ^{[1
]}

机构：

[1] HARVARD UNIV,SCH MED,BOSTON,MA 02115

来源：

关键词：

D O I：

10.1001/archinte.148.12.2571

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2571 / 2576

页数：6

共 21 条

[1] BERENDT MJ, 1980, J EXP MED, V151, P69, DOI 10.1084/jem.151.1.69
[2] CHEEVER MA, 1980, J IMMUNOL, V125, P711
[3] DOMZIG W, 1983, J IMMUNOL, V130, P1970
[4] EBERLEIN TJ, 1982, JNCI-J NATL CANCER I, V69, P109
[5] EBERLEIN TJ, 1982, J EXP MED, V156, P385
[6] EBERLEIN TJ, 1982, CANCER IMMUNOL IMMUN, V13, P5
[7] EBERLEIN TJ, 1981, SURG FORUM, V32, P452
[8] RECOMBINANT HUMAN INTERLEUKIN-2 ACTS AS A B-CELL GROWTH AND DIFFERENTIATION PROMOTING FACTOR
EMMRICH, F
MOLL, H
SIMON, MM
[J]. IMMUNOBIOLOGY, 1985, 169 (01) : 97 - 102
[9] ETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P3623
[10] FERNANDEZCRUZ E, 1979, J IMMUNOL, V123, P1772